Automated brain volumetry and neurotrauma decision-support tools trusted by 220+ clinical sites worldwide. Affordable, accessible, and built for precision medicine.
From automated brain MR volumetry to CT-based neurotrauma triage — a comprehensive platform for neurologists, neuroradiologists, and neurosurgeons.
Fully automated brain volumetry from 3D MRI using AI/Deep Net/3D Convolutional Networks. The world's first tool providing ethnicity-specific reference ranges adjusted to age, gender, and ethnicity — bringing precision medicine to neurodegenerative disease management.
AI-based neurotrauma screening and quantification tool for Traumatic Brain Injury. Automates stroke lesion segmentation and midline shift detection, supporting rapid clinical decision-making in critical care.
Neurology workflow software that streamlines clinical operations — from scan intake to report delivery. Reduces radiologist burden through intelligent automation and centralized data visualization.
Sports-specific whole-body MRI assessment providing tissue distribution profiling, body mass analysis, and athletic wellness evaluation. Built for elite sports performance and injury prevention.
From worklist management to fully automated volumetric reports — a complete clinical decision-support workflow.
Centralized scan management across all sites. Upload studies, track processing status, filter by site, status, and demographics — all in real time.
Comprehensive brain structure analysis with absolute volumes, ICV percentages, and age/gender/ethnicity-adjusted reference ranges across 30+ structures.
Color-coded segmentation overlay across axial, sagittal, and coronal planes. Interactive viewer with zoom, pan, and region-level inspection.
NeuroShield has been rigorously validated and cleared by the US FDA as a clinical decision-support tool for neurologists and neuroradiologists.
Clinical Decision Support Tool for Neurologists & Neuroradiologists
Demonstrated high accuracy across scanner strengths, demographic subgroups, age ranges, and geographic regions.
Validated across 1.5T and 3T scanners from multiple manufacturers. Scanner-agnostic architecture.
Ground truth established by 3 US Board-Certified Radiologists using the STAPLE consensus algorithm.
World's first volumetric tool with ranges adjusted to age, gender, and ethnicity for equitable precision medicine.
InMed Prognostics Inc. is a pioneer in AI-driven predictive analytics, leveraging multi-modal data — including text, signal, and image — to build fully automated, organ-agnostic imaging platforms (US Patent No. 11263749).
Founded by Dr. Latha Poonamallee, InMed operates across India, Africa, and the Middle East, with deep expertise in developing and deploying automated image processing algorithms and AI/ML pipelines at clinical scale.
The company is expanding its product portfolio into CT Brain applications, Whole Body MRI wellness and athletic solutions, and lesion detection for pancreatic and liver cancer.
Ph.D., Case Western Reserve University, Cleveland, Ohio. Pioneer in AI-driven predictive analytics and precision medicine. Leading InMed's mission to bring affordable, accessible healthcare tools to everyone, everywhere.
Ph.D., Stanford University. Deep expertise in building and deploying fully automated image processing algorithms, AI/ML pipelines, and scalable cloud platforms for clinical-grade medical imaging.
Request a demo, start a 30-day free trial, or speak with our clinical solutions team.
6th Floor, Awfis Kode 2,
Baner Pashan Link Road, Baner,
Pune, Maharashtra, India
Golden Galaxy, Pashan,
Pune, Maharashtra, India
India • Africa • Middle East • USA
Intended Use Disclaimer: NeuroShield is intended as a clinical decision-support tool to assist qualified healthcare professionals. It is not intended to replace clinical judgment, provide a definitive diagnosis, or be used as the sole basis for clinical decisions. NeuroShield MR Volumetry is US FDA 510(k) cleared (K220034). Product availability may vary by region and regulatory status. All claims regarding product performance refer to data obtained during controlled clinical validation studies. For full prescribing information and indications for use, contact InMed.AI.